Navigation Links
EXXCEL™ Soft Vascular Graft

ProductsEXXCEL™ Soft Vascular Graft
Company Boston Scientific Corporation
Item EXXCEL™ Soft Vascular Graft
Features 
  • Kink Resistance promotes increased flow dynamics by preserving the graft lumen shape, a feature important for dialysis fistula placement when creating a small vessel loop or for peripheral procedures where unexpected tortuosity requires flexibility.
  • Crush resistance promotes an open graft lumen both during and after the procedure. Compression resistance is the ability of the graft to maintain an open lumen shape for ease of hood fashioning as well as for graft patency post implantation.
  • Combination of soft but strong graft means excellent handling during surgery. It has superior handling characteristics providing for excellent conformability and suturability, and resists tearing when cut.
  • Consistent strength throughout the graft promotes fewer weak points in the macrostructure of the product.
  • The Exxcel Soft graft is designed to perform well along the line of the anastomosis where suture retention is important and in dialysis applications where the graft will be punctured repeatedly.
  • Secure continuous support coil promotes additional graft strength across joints, at crucial flex points, or where added support is required. The support coil detaches in a continuous manner facilitating customization during the procedure.
Description Exxcel Soft ePTFE vascular graft, designed for exceptional kink resistance and crush resistance, maintains a Soft touch for easier handling during peripheral vascular bypass procedures and vascular access procedures for dialysis access management.
Info Boston Scientific Corporation
Customer Service: (888) 272-1001
Web site: http://www.bostonscientific.com

Related medicine products :

1. Vascular Clamps B-1
2. Vascular Clamps B-2
3. Vascular Clamps B-3
4. Vascular Clamps HD-S
5. Vascular Clamps RD-S
6. Vascular Clamps ABB-11
7. Vasoguard Vascular Doppler
8. VersaLab Vascular Doppler
9. Vasoguard Microlite Vascular Doppler
10. PINNACLE Introducer Sheath Designed for Vascular Access
11. CVS4 Complete Vascular System
Double Ended Occluders
Double Ended Occluders
Long handle occluders are approximately 9 inches long.
Basic external reading model.
Medicine Products:
(Date:12/3/2008)...Great, a MED3OOO company that,delivers EHR techno...y,clinics, recently entered into a 14-year Applic...HealthCare Alliance to provide electronic medical ... , The WVVA Healthcare Alliance is made up ...in the Alleghany Highlands of Virginia and the Gre...
(Date:12/3/2008)...rs stress, study finds , , WEDNESDAY, De...ercises can improve a patient,s quality of life, t...to a study by Scottish researchers. , The Unive... being treated for mild to moderately severe asthm...ons of breathing exercise training provided by a p...
(Date:12/3/2008)...ess responsible uses, claims, experts say , ...sive, sham stem cell therapies are being hawked di...perts say. , In response, the leading organizat...idelines to steer research in the field toward res... is progressing so rapidly and has sparked a lot o...
(Date:12/3/2008)... Many dentists and dental office,staff have reali...owever, very,few dental professionals have taken ...electronic transactions may increase office effici...ng benefit information while the patient is still,...lly take 10 to 14 business days to process. By,us...
Breaking Medicine News(10 mins):Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 2Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 3Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 4Health News:Bogus Stem Cell Therapies Sold on Internet 2Health News:Bogus Stem Cell Therapies Sold on Internet 3Health News:Electronic Submission for Dental Predeterminations May Increase Efficiency, Patient Satisfaction 2
...sis develops when the tissues lining the uterus gr...er organs in the abdomen. // The condition can cau...re fruits and vegetables are less likely to suffer...ometriosis, shows a new study. Researchers surveye...
... doctors thought of rickets as a disease of the pa...ed a problem and prevention should // start befor...uld be given vitamin D supplementation. Rickets is...g and weakening of the bones, primarily caused by ...
...l considered major surgery, heart transplantation ...ime, problems arise //after the person goes home. ...n the horizon is helping transplant patients lead ...wo major problems after surgery -- rejection of th...
... cancer is the third most common cancer worldwide ...ing the risk of colorectal cancer.//High milk cons...ated with a lower risk of colorectal cancer. Among...y milk consumption was linked to a decreased risk ...
Other Medicine News:
(Date:12/2/2008)...NEXA, Kan., Dec. 2 IBT Laboratorie...research laboratory specializing in immunology and...o tests to evaluate the response of patients who...ary immunodeficiency disorder, chemotherapy drugs,...gs to prevent rejection of a transplant. The compa...
(Date:12/1/2008)...ICAGO, Dec. 2 New resea...eight-slice computed tomography (CT) scanner in an...ber of stroke victims who receive a potentially li...ed at North Shore Medical Center (NSMC)-Salem Hosp...he annual meeting of the Radiological Society of N...
(Date:12/1/2008)...NGAPORE, Dec. 1 S*BIO Pte Ltd toda... trial of SB1518, a potent and orally-active JAK2 ... for patients with chronic idiopathic myelofibrosi...luate the safety and tolerability of SB1518 in pat...patients. The Phase 1 part of the study will asse...
(Date:12/1/2008)..., Abstinence is still the best policy , , ... -- A new study from Mayo Clinic finds the use of ...g alcoholic hepatitis, an acute inflammation of th.... The results of the study are published in the De...strojournal.org/ ). , , VIDEO ALERT: Addit...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT 6768 1Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT 6768 2People with Disabilities Seek Ways to Manage Higher Healthcare Costs 24476 1People with Disabilities Seek Ways to Manage Higher Healthcare Costs 24476 2People with Disabilities Seek Ways to Manage Higher Healthcare Costs 24476 3People with Disabilities Seek Ways to Manage Higher Healthcare Costs 24476 4People with Disabilities Seek Ways to Manage Higher Healthcare Costs 24476 5CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health 24471 1CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health 24471 2CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health 24471 3CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health 24471 4Bariatric patients have 65 25 lower chance of complications at top hospitals 3A HealthGrades study 24466 1Bariatric patients have 65 25 lower chance of complications at top hospitals 3A HealthGrades study 24466 2Bariatric patients have 65 25 lower chance of complications at top hospitals 3A HealthGrades study 24466 3
...l 23, 2007--A part of the brain first,affected by ...://www.nia.nih.gov/Alzheimers/">http://www.nia.nih... gene for the disorder, a brain,imaging study by r...lth (NIMH), one of the National Institutes of Heal...a structure in the lower middle,part of the brains...
...equivalent Pharmacokinetics With Reduced Risk,of H... April 25, 2007 /PRNewswire-FirstCall/ -- ADVENTRX...rch and,development company focused on commerciali...ent of cancer and infectious diseases,today annou...etic,testing of ANX-514 (docetaxel emulsion) in a ...
Other Medicine Technology:Cortex Area Thinner in Youth with Alzheimers-Related Gene 2Cortex Area Thinner in Youth with Alzheimers-Related Gene 3Cortex Area Thinner in Youth with Alzheimers-Related Gene 4ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic,Testing of ANX-514 (Docetaxel Emulsion) 2ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic,Testing of ANX-514 (Docetaxel Emulsion) 3ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic,Testing of ANX-514 (Docetaxel Emulsion) 4ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic,Testing of ANX-514 (Docetaxel Emulsion) 5